← Back to explorer

2023/0491 - BLINATUMOMAB [38.5 µG PÓ CONC SOL SOL INJ FRS]

TED · 428511-2026can-standardawardedNo deadline given

Buyer

NameUnidade Local de Saúde Santa Maria, E.P.E.

CountryPT

Published2026-06-24

Deadline

Value

Estimated€83,261 · 83,261.2 EUR

Awarded

WinnerAMGEN BIOFARMACEUTICA, LDA

See this firm's wins →

CPV codes

33600000 Medical equipment & pharmaceuticals

Description

BLINATUMOMAB [38.5 µG PÓ CONC SOL SOL INJ FRS]

Similar tenders

Closest by meaning — across languages, via embeddings.

PublishedTitleBuyerMatch
2026-06-242023/0491 - BLINATUMOMAB [38.5 µG PÓ CONC SOL SOL INJ FRS]Unidade Local de Saúde Santa Maria, E.P.E. PT100%
2026-06-242023/0491 - ECULIZUMAB [300 MG SOL INJ FRS]Unidade Local de Saúde Santa Maria, E.P.E. PT96%
2026-06-242023/0491 - ECULIZUMAB [300 MG SOL INJ FRS]Unidade Local de Saúde Santa Maria, E.P.E. PT96%
2026-06-242023/0491 - VEDOLIZUMAB [300 MG PÓ CONC SOL INJ FRS]Unidade Local de Saúde Santa Maria, E.P.E. PT96%
2026-06-242023/0491 - VEDOLIZUMAB [300 MG PÓ CONC SOL INJ FRS]Unidade Local de Saúde Santa Maria, E.P.E. PT96%
2026-06-022023/0491 - NIVOLUMAB [10 MG/ML 10 ML SOL INJ FRS]Unidade Local de Saúde Santa Maria, E.P.E. PT96%

Source

View the official notice on TED